Mutual of America Capital Management LLC Sells 730 Shares of Cardinal Health, Inc. $CAH

Mutual of America Capital Management LLC cut its position in Cardinal Health, Inc. (NYSE:CAH) by 2.6% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,425 shares of the company’s stock after selling 730 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Cardinal Health were worth $4,607,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Greykasell Wealth Strategies Inc. bought a new stake in shares of Cardinal Health during the 1st quarter worth approximately $26,000. GW&K Investment Management LLC lifted its stake in shares of Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after acquiring an additional 144 shares during the last quarter. Harbor Asset Planning Inc. bought a new position in shares of Cardinal Health in the 2nd quarter valued at $49,000. Zions Bancorporation National Association UT bought a new position in shares of Cardinal Health in the 1st quarter valued at $52,000. Finally, Atwood & Palmer Inc. raised its position in Cardinal Health by 57.5% in the second quarter. Atwood & Palmer Inc. now owns 389 shares of the company’s stock valued at $65,000 after purchasing an additional 142 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $159.62 on Thursday. The firm has a market capitalization of $37.92 billion, a price-to-earnings ratio of 24.75, a PEG ratio of 1.34 and a beta of 0.71. The business has a 50-day simple moving average of $152.33 and a 200 day simple moving average of $152.20. Cardinal Health, Inc. has a one year low of $106.98 and a one year high of $168.44.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the prior year, the company posted $1.84 earnings per share. Cardinal Health’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were paid a dividend of $0.5107 per share. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio is presently 31.63%.

Analyst Ratings Changes

A number of brokerages recently issued reports on CAH. Argus set a $189.00 price objective on shares of Cardinal Health in a report on Friday, August 22nd. Robert W. Baird raised their price target on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research report on Tuesday, August 12th. Finally, UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus target price of $166.00.

Insider Activity at Cardinal Health

In related news, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the transaction, the insider directly owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the transaction, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at $3,881,969.70. The trade was a 61.45% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 in the last three months. Corporate insiders own 0.12% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.